Table 5.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Kidney Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		10,088	10,581	10,877	11,237	11,977	12,247	13,066	13,794	14,332	14,715
With Immunosuppression Info		9,548	10,355	10,674	11,191	11,907	12,047	12,837	13,754	14,267	14,464
Corticosteroids	Category Usage	93.1%	93.3%	97.1%	97.4%	96.5%	97.3%	95.6%	93.5%	91.1%	84.8%
	Steroids	93.1%	93.3%	97.1%	97.4%	96.5%	97.3%	95.6%	93.5%	91.1%	84.8%
Cyclosporine	Category Usage	86.2%	81.7%	75.8%	76.5%	67.7%	61.5%	51.2%	37.5%	29.8%	25.8%
	Cyclosporin	84.6%	73.7%	8.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	1.9%	6.0%	12.4%	7.4%	5.4%	5.4%	3.1%	2.5%	1.4%	0.9%
	Neoral	0.2%	6.3%	59.4%	69.6%	62.7%	56.3%	47.5%	30.2%	21.7%	19.3%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.9%	4.8%	6.6%	5.6%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.2%	0.1%
Tacrolimus	Category Usage	5.2%	6.7%	12.5%	18.7%	26.4%	32.8%	44.0%	56.4%	63.8%	66.8%
	FK506	5.2%	6.7%	12.5%	18.7%	26.4%	32.8%	44.0%	56.4%	63.8%	66.8%
Antimetabolites	Category Usage	78.4%	77.4%	80.5%	86.5%	85.1%	86.2%	80.3%	79.7%	81.6%	82.4%
	Azathioprine	78.4%	64.6%	31.8%	20.0%	12.1%	7.9%	5.3%	4.1%	2.3%	1.8%
	Mycophenolate mofetil	0.0%	13.7%	50.3%	67.3%	73.8%	78.6%	75.2%	76.0%	79.5%	80.9%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.0%	0.0%	0.2%	0.2%	0.1%	0.2%	0.2%	0.1%	0.1%	0.1%
Other	Category Usage	0.0%	0.1%	1.5%	3.4%	3.0%	2.5%	13.0%	17.2%	15.0%	15.5%
	Rapamycin	0.0%	0.1%	1.5%	3.4%	3.0%	2.5%	13.0%	17.2%	15.0%	15.5%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.